Bing

SEARCH HISTORY

Given its very active portfolio that had a high degree of turnover, we will now take a look at Stevens Capital’s top new positions which are Altria Group Inc (NYSE:MO), Celgene Corporation ... shares of its common stock. Among other things, the company ...
INSIDER MONKEY · 5/11/2015
[Business Wire] – Celgene Corporation plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be we Read more on this.
Jutia Group · 1/27/2015
Mid cap cancer stock Juno Therapeutics Inc (NASDAQ ... BLCM) along with large cap Celgene Corporation (NASDAQ: CELG). I should mention that we have just added Juno Therapeutics to our SmallCap Network Elite Opportunity (SCN EO) portfolio as …
Smallcap Network · ByJohn Udovich · 6/26/2015
SUMMIT, N.J., Jun 19, 2014 (BUSINESS WIRE) -- Celgene Corporation CELG, -2.96% today announced that its stockholders approved a two-for-one stock split and an increase from 575 million to 1,150 million in the number of authorized shares of the …
Market Watch · 6/19/2014
Celgene Corporation (NASDAQ:CELG), Kinder Morgan Inc (NYSE:KMI), Chipotle Mexican Grill, Inc. (NYSE:CMG) are among the top stock picks of Jim Cramer over the last 30 days. Cramer has mentioned each of these stocks at least 4 times during the …
stockwisedaily.com · 11/24/2014
Shares of Seattle-based biotech startup Juno Therapeutics spiked more than 60 percent in after-hours trading on Monday after the company announced a $1 billion investment from Celgene. The 10-year “collaboration” will allow Celgene to commercialize ...
Geek Wire · 6/29/2015
Celgene Corp. (NASDAQ: CELG) has decided to join the stock split game. Stock splits do not create any fundamental change on the surface, but the problem that Celgene has faced is that the run up in shares has lowered its average daily volume. The …
24/7 Wall ST · 6/19/2014
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that its stockholders approved a two-for-one stock split and an increase from 575 million to 1,150 million in the number of authorized shares of the Company's …
Business Wire · 6/19/2014
Shares of Celgene Corp (CELG.O) rose as much as 9.7 percent on Monday after a late-stage clinical trial showed its drug Abraxane improved survival in patients with pancreatic cancer. Celgene, which unexpectedly reported the results late on Friday ...
Reuters · ByToni Clarke · 11/12/2012
A key contributor to Celgene's outsize stock performance this year has been investor read-through from management's confidence on hitting near-and long-term financial metrics. Investors should not be surprised to have management be similarly bullish on ...
istock Analyst · 1/8/2014

Celgene

Company
Celgene Corporation is an American biotechnology company that manufactures drug therapies for cancer and inflammatory disorders. I…
Celgene Corporation is an American biotechnology company that manufactures drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major products are Thalomid, which is approved for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum, as well as in combination with dexamethasone for patients with newly diagnosed multiple myeloma, and Revlimid, for which the company has received FDA and EMA approval in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate …
Data from: Wikipedia